Over-expression of regulator of G protein signaling 5 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells

Journal of Surgical Oncology

Volumn 108, Issue 3, 2013, Pages 192-196

  Hu, Minghua ^a   Chen, Xiaobing ^b,c   Zhang, Jianmin ^d   Wang, Dong ^a   Fang, Xiaosan ^a   Wang, Xiaoming ^a   Wang, Guannan ^a   Chen, Guoyong ^c   Jiang, Xiaochun ^a   Xia, Hongping ^a   Wang, Yongsheng ^e  

^a WANNAN MEDICAL COLLEGE   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c People's Hospital of Zhengzhou   (China)

^d LINYI PEOPLE'S HOSPITAL   (China)

^e MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

epithelial mesenchymal transition; hepatocellular carcinoma; recurrence; RGS5

Indexed keywords

REGULATOR OF G PROTEIN SIGNALING 5; RGS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; VASCULAR TUMOR; WESTERN BLOTTING;

EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR CARCINOMA; RECURRENCE; RGS5;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RGS PROTEINS;

EID: 84881193257     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23367     Document Type: Article

References (14)

1. Forner A, Llovet JM, Bruix J:, Hepatocellular carcinoma. Lancet 379: 1245-1255.
2. Ye Q-H, Qin L-X, Forgues M, et al.: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9: 416-423.
3. Guichard C, Amaddeo G, Imbeaud S, et al.: Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-698.
4. Hamzah J, Jugold M, Kiessling F, et al.: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 2008; 453: 410-414.
5. Furuya M, Nishiyama M, Kimura S, et al.: Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. J Pathol 2004; 203: 551-558.
6. Wang J-H, Huang W-S, Hu C-R, et al.: Relationship between RGS5 expression and differentiation and angiogenesis of gastric carcinoma. World J Gastroenterol 2010; 16: 5642.
7. Huang G, Song H, Wang R, et al.: The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer. J Surg Oncol 2012; 105: 420-424.
8. Koh J, Dar M, Untch BR, et al.: Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor. Mol Endocrinol 2011; 25: 867-876.
9. Xia H, Ooi LLPJ, Hui KM:, MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS ONE 2012; 7: e44206.
10. Livak KJ, Schmittgen TD:, Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 2001; 25: 402-408.
11. Voulgari A, Pintzas A:, Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009; 1796: 75-90.
12. Kong D, Li Y, Wang Z, et al. Cancer stem cells and epithelial-to- mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins ? Cancers 2011; 3: 716-729.
13. Zeisberg M, Neilson EG:, Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429-1437.
14. Manzur M, Hamzah J, Ganss R:, Modulation of g protein signaling normalizes tumor vessels. Cancer Res 2009; 69: 396-399.